Rahul S. Dalal, MD, MPH (he/him/his)

Brigham and Women's Hospital, Harvard Medical School
Boston, MA

Presentation(s):

• 71 - Real-World Comparative Effectiveness of Vedolizumab versus Upadacitinib and Risankizumab for Crohn’s Disease Through 52 Weeks

  Wednesday, October 29, 2025
  9:30 AM - 9:40 AM PDT